Convalescent Plasma / Hospital San Jose Tec De Monterrey - LARVOL DELTA

Safety in Convalescent Plasma Transfusion to COVID-19 (clinicaltrials.gov) - P1; N=12; Terminated; Sponsor: Hospital San Jose Tec de Monterrey; N=20 ➔ 12; Trial completion date: Apr 2021 ➔ Aug 2020; Recruiting ➔ Terminated; Trial primary completion date: Dec 2020 ➔ Aug 2020; Other clinical trails probed that the use of convalescent plasma for patients with COVID-19 is safe .

Clinical • Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

EPCOvid-1: Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19 (clinicaltrials.gov) - P2b; N=410; Recruiting; Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Not yet recruiting ➔ Recruiting; N=250 ➔ 410

Enrollment change • Enrollment open • Infectious Disease • Novel Coronavirus Disease

EPCOvid-1: Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19 (clinicaltrials.gov) - P2b; N=250; Not yet recruiting; Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Clinical • New P2b trial • Infectious Disease • Novel Coronavirus Disease

Safety in Convalescent Plasma Transfusion to COVID-19 (clinicaltrials.gov) - P1; N=20; Recruiting; Sponsor: Hospital San Jose Tec de Monterrey; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Infectious Disease • Novel Coronavirus Disease

Safety in Convalescent Plasma Transfusion to COVID-19 (clinicaltrials.gov) - P1; N=20; Not yet recruiting; Sponsor: Hospital San Jose Tec de Monterrey

Clinical • New P1 trial